CACNA1A and Familial paroxysmal ataxia: Moreover, given the encouraging outcome reported by Martakis and colleagues that N-acetyl-leucine acts as a new potential treatment for CACNA1A-related disorders, we predict that this compound could be beneficial for CACNA1A-related episodic ataxia [34].